Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.

Cancer - 15 Jan 2012

Schwartz Marc D, Isaacs Claudine, Graves Kristi D, Poggi Elizabeth, Peshkin Beth N, Gell Christy, Finch Clinton, Kelly Scott, Taylor Kathryn L, Perley Lauren

Abstract excerpt

BACKGROUND: For BRCA1/BRCA2 gene testing to benefit public health, mutation carriers must initiate appropriate risk management strategies. There has been little research examining the long-term use and prospective predictors of the full range of risk management behaviors among women who have unde...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer
Share to Genes, BRCA2
Share to Mastectomy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Outcome Assessment, Health Care

Share to Ovariectomy

Share to Patient Compliance

Share to Risk Reduction Behavior

Share to Salpingectomy

Source

Open in PubMed Open full text

Identifiers

PMID: 21717445
DOI: 10.1002/cncr.26294
PMCID: PMC3286617

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21717445-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.PMID 21717445Read ↗

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.Semantic proximity Read ↗

BRCA1/2 test results impact risk management attitudes, intentions, and uptake.Semantic proximity Read ↗

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.Semantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis.Semantic proximity Read ↗

A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes.Semantic proximity Read ↗

Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review.Semantic proximity Read ↗

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.Semantic proximity Read ↗

Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing forBRCA-Related Cancer in WomenSemantic proximity Read ↗

Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers.Semantic proximity Read ↗

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.